XML 49 R43.htm IDEA: XBRL DOCUMENT v3.25.2
Collaboration and License Agreements - Additional Information (Detail)
1 Months Ended 3 Months Ended 6 Months Ended
Feb. 28, 2022
USD ($)
Nov. 30, 2022
Jun. 30, 2025
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
Units
Jun. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Revenue not from contract with customer           $ 251,000      
Other receivable current     $ 30,000   $ 30,000   $ 146,000    
Option And License Agreement With GC Cell [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Number of products units for which the option has been exercised by the company | Units         4        
Royalty percentage to be paid by the counterparty         50.00%        
AB-101 Selected Product License Agreement with GC cell [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Royalty percentage to be paid by the counterparty 50.00%                
AB-101 Selected Product License Agreement with GC cell [Member] | Development milestone [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Milestone amount payable $ 22,000,000                
AB-101 Selected Product License Agreement with GC cell [Member] | Sales milestone [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Milestone amount payable $ 55,000,000                
Milestone Amount Recognized         $ 0        
Royaly expenses recognized         0        
AB-201 Selected Product License Agreement with GC cell [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Royalty percentage to be paid by the counterparty 50.00%                
Revenue not from contract with customer     0 $ 0 0 300,000      
Accounts receivable net current     0   0   0    
AB-201 Selected Product License Agreement with GC cell [Member] | Development milestone [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Milestone amount payable $ 25,000,000                
Milestone payment receivable               $ 1,800,000  
AB-201 Selected Product License Agreement with GC cell [Member] | Sales milestone [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Milestone amount payable $ 55,000,000                
AB-205 Selected Product License Agreement with GC cell [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Milestone Amount Recognized         0        
Royaly expenses recognized         0        
Accounts receivable net current                 $ 2,500,000
Research and development expenses reimbursed     0 0 0 100,000      
Other receivable current     0   0   $ 0    
Receipt from the counterparty     $ 0   0        
AB-205 Selected Product License Agreement with GC cell [Member] | Development milestone [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Milestone amount payable                 29,500,000
AB-205 Selected Product License Agreement with GC cell [Member] | Sales milestone [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Milestone payment receivable                 $ 28,000,000
Affimed collaboration agreement [Member]                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Percentage of costs to be incurred in connection with the performance of confimatory combination   50.00%              
Percentage of costs to be borne by the counterparty   50.00%              
Revenue share of the company in percentage     67.00%            
Revenue share of the counterparty in percentage     33.00%            
Expenses incurred in connection with the agreement     $ 17,000 $ 0 37,000 $ 100,000      
Termination fee payable         $ 0